Feedback / Questions
nanatinostat (VRx-3996) - Viracta Therap
https://www.prnewswire.com/news-releases/viracta-therapeutics-reports-first-quarter-2021-financial-results-and-provides-clinical-and-corporate-updates-301290173.html
May 12, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next